Evidence map›Paper›PMID 39305962›Full record

ArticleThe Journal of biological chemistry2024

The ubiquitin-specific protease 21 is critical for cancer cell mitochondrial function and regulates proliferation and migration.

Magdalena Kulma, Bartłomiej Hofman, Małgorzata Szostakowska-Rodzoś, Dorota Dymkowska, Remigiusz A Serwa, Katarzyna Piwowar, Agnieszka Belczyk-Ciesielska, Joanna Grochowska, Irina Tuszyńska, Angelika Muchowicz and 3 more

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Magdalena KulmaMolecure SA, Warsaw, Poland. Electronic address: m.kulma@molecure.com.
Bartłomiej HofmanMolecure SA, Warsaw, Poland.
Małgorzata Szostakowska-RodzośMolecure SA, Warsaw, Poland.
Dorota DymkowskaLaboratory of Cellular Metabolism, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
Remigiusz A SerwaIMol, Polish Academy of Sciences, Warsaw, Poland; ReMedy International Research Agenda Unit, IMol, Polish Academy of Sciences, Warsaw, Poland.
Katarzyna PiwowarMolecure SA, Warsaw, Poland.
Agnieszka Belczyk-CiesielskaMolecure SA, Warsaw, Poland.
Joanna GrochowskaMolecure SA, Warsaw, Poland.
Irina TuszyńskaMolecure SA, Warsaw, Poland.
Angelika MuchowiczMolecure SA, Warsaw, Poland.
Katarzyna DrzewickaMolecure SA, Warsaw, Poland.
Krzysztof ZabłockiLaboratory of Cellular Metabolism, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
Zbigniew ZasłonaMolecure SA, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ubiquitin-specific proteases (USPs) are the main members of deubiquitinases (DUBs) that catalyze removing ubiquitin chains from target proteins, thereby modulating their half-life and function. Enzymatic activity of USP21 regulates protein degradation which is critical for maintaining cell homeostasis. USP21 determines the stability of oncogenic proteins and therefore is implicated in carcinogenesis. In this study, we investigated the effect of USP21 deletion on cancer cell metabolism. Transcriptomic and proteomic analysis of USP21 KO HAP-1 cells revealed that endogenous USP21 is critical for the expression of genes and proteins involved in mitochondrial function. Additionally, we have found that the deletion of USP21 reduced STAT3 activation and STAT3-dependent gene and protein expression in cancer cells. Genetic deletion of USP21 impaired mitochondrial respiration and disturbed ATP production. This resulted in cellular consequences such as inhibition of cell proliferation and migration. Presented results provide new insights into the biology of USP21, suggesting novel mechanisms for controlling STAT3 activity and mitochondrial function in tumor cells. Taken together, our findings indicate that targeting USP21 dysregulates the energy status of cancer cells offering new perspectives for anticancer therapy.

Indexed as

Cell MovementCell ProliferationMitochondriaSTAT3 Transcription FactorUbiquitin ThiolesteraseCell Line, TumorGene Expression Regulation, NeoplasticHumansNeoplasmsSTAT3 protein, humanSTAT3 Transcription FactorUbiquitin ThiolesteraseUSP21 protein, humanATPbioenergycancer metabolismdeubiquitinationSTAT3USP21

Identifiers

PMID39305962
PMCPMC11513602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.